Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)

Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS...

Full description

Saved in:
Bibliographic Details
Published in:Biomedical reports 2024-05, Vol.20 (5), p.80-80, Article 80
Main Authors: Raihanah, Cut, Sukrasno, Sukrasno, Kurniati, Neng Fisheri
Format: Article
Language:English
Subjects:
Abdomen
Acne
Alopecia
Androgens
Antioxidants
Baldness
Birth control
Clinical trials
Drugs
Enzymes
Estrogens
Females
Hormones
In vivo methods and tests
Inflammation
Insulin resistance
Isoflavones
Medical research
Medicine, Experimental
Menstrual cycle
Menstruation
Metabolic disorders
Metabolism
Obesity
Ovaries
Oxidative stress
Phytoestrogens
Polycystic ovary syndrome
Review
Side effects
Stein-Leventhal syndrome
Testosterone
Weight control
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c437t-59d09ba3f109280757974a754440469d824dfd7890c31ee082d9c01fe507a083
container_end_page 80
container_issue 5
container_start_page 80
container_title Biomedical reports
container_volume 20
creator Raihanah, Cut
Sukrasno, Sukrasno
Kurniati, Neng Fisheri
description Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on and clinical trial studies.
doi_str_mv 10.3892/br.2024.1768
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10999901</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A791885305</galeid><sourcerecordid>A791885305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-59d09ba3f109280757974a754440469d824dfd7890c31ee082d9c01fe507a083</originalsourceid><addsrcrecordid>eNptkt9LHDEQx0OpVFHf-iwLvih452x-XJKnckhrC2JBfA-5bHJGdpMz2VvZ_94s2mstTh4yJJ_5TmYyCH2tYU6ExJerNMeA6bzmC_EJHWCgciYpxZ93PqH76DjnRygmOWAmvqB9IpgESdkBul2a3g--H6voKp-ja_UQg618qDod9NqHdbWJ7WjG3HtTxUGnscpjaFLsbHG6TR-7XJ3d2cHb5_MjtOd0m-3x236I7n98v7_6Obv5ff3rankzM5TwfsZkA3KliatBYgGcccmp5oxSCnQhG4Fp4xouJBhSWwsCN9JA7SwDrkGQQ_TtVXazXXW2MTb0Sbdqk3xX3qei9ur9TfAPah0HVfIVg7oonL0ppPi0tblXnc_Gtq0ONm6zIkBKrgWRUNDT_9DHuE2hlDdRcsGJIOIvtdatVT64WBKbSVQtuayFYARYoeYfUGU1tvOmNN75cv4u4OI1wKSYc7JuV2QNahoBtUpqGgE1jUDBT_5tzA7-8-HkBcM9qiE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3039673838</pqid></control><display><type>article</type><title>Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)</title><source>PubMed Central</source><creator>Raihanah, Cut ; Sukrasno, Sukrasno ; Kurniati, Neng Fisheri</creator><creatorcontrib>Raihanah, Cut ; Sukrasno, Sukrasno ; Kurniati, Neng Fisheri</creatorcontrib><description>Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on and clinical trial studies.</description><identifier>ISSN: 2049-9434</identifier><identifier>EISSN: 2049-9442</identifier><identifier>DOI: 10.3892/br.2024.1768</identifier><identifier>PMID: 38590945</identifier><language>eng</language><publisher>England: Spandidos Publications</publisher><subject>Abdomen ; Acne ; Alopecia ; Androgens ; Antioxidants ; Baldness ; Birth control ; Clinical trials ; Drugs ; Enzymes ; Estrogens ; Females ; Hormones ; In vivo methods and tests ; Inflammation ; Insulin resistance ; Isoflavones ; Medical research ; Medicine, Experimental ; Menstrual cycle ; Menstruation ; Metabolic disorders ; Metabolism ; Obesity ; Ovaries ; Oxidative stress ; Phytoestrogens ; Polycystic ovary syndrome ; Review ; Side effects ; Stein-Leventhal syndrome ; Testosterone ; Weight control</subject><ispartof>Biomedical reports, 2024-05, Vol.20 (5), p.80-80, Article 80</ispartof><rights>Copyright: © 2024 Raihanah et al.</rights><rights>COPYRIGHT 2024 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2024</rights><rights>Copyright: © 2024 Raihanah et al. 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c437t-59d09ba3f109280757974a754440469d824dfd7890c31ee082d9c01fe507a083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999901/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999901/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38590945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raihanah, Cut</creatorcontrib><creatorcontrib>Sukrasno, Sukrasno</creatorcontrib><creatorcontrib>Kurniati, Neng Fisheri</creatorcontrib><title>Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)</title><title>Biomedical reports</title><addtitle>Biomed Rep</addtitle><description>Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on and clinical trial studies.</description><subject>Abdomen</subject><subject>Acne</subject><subject>Alopecia</subject><subject>Androgens</subject><subject>Antioxidants</subject><subject>Baldness</subject><subject>Birth control</subject><subject>Clinical trials</subject><subject>Drugs</subject><subject>Enzymes</subject><subject>Estrogens</subject><subject>Females</subject><subject>Hormones</subject><subject>In vivo methods and tests</subject><subject>Inflammation</subject><subject>Insulin resistance</subject><subject>Isoflavones</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Menstrual cycle</subject><subject>Menstruation</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Obesity</subject><subject>Ovaries</subject><subject>Oxidative stress</subject><subject>Phytoestrogens</subject><subject>Polycystic ovary syndrome</subject><subject>Review</subject><subject>Side effects</subject><subject>Stein-Leventhal syndrome</subject><subject>Testosterone</subject><subject>Weight control</subject><issn>2049-9434</issn><issn>2049-9442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNptkt9LHDEQx0OpVFHf-iwLvih452x-XJKnckhrC2JBfA-5bHJGdpMz2VvZ_94s2mstTh4yJJ_5TmYyCH2tYU6ExJerNMeA6bzmC_EJHWCgciYpxZ93PqH76DjnRygmOWAmvqB9IpgESdkBul2a3g--H6voKp-ja_UQg618qDod9NqHdbWJ7WjG3HtTxUGnscpjaFLsbHG6TR-7XJ3d2cHb5_MjtOd0m-3x236I7n98v7_6Obv5ff3rankzM5TwfsZkA3KliatBYgGcccmp5oxSCnQhG4Fp4xouJBhSWwsCN9JA7SwDrkGQQ_TtVXazXXW2MTb0Sbdqk3xX3qei9ur9TfAPah0HVfIVg7oonL0ppPi0tblXnc_Gtq0ONm6zIkBKrgWRUNDT_9DHuE2hlDdRcsGJIOIvtdatVT64WBKbSVQtuayFYARYoeYfUGU1tvOmNN75cv4u4OI1wKSYc7JuV2QNahoBtUpqGgE1jUDBT_5tzA7-8-HkBcM9qiE</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Raihanah, Cut</creator><creator>Sukrasno, Sukrasno</creator><creator>Kurniati, Neng Fisheri</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240501</creationdate><title>Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)</title><author>Raihanah, Cut ; Sukrasno, Sukrasno ; Kurniati, Neng Fisheri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-59d09ba3f109280757974a754440469d824dfd7890c31ee082d9c01fe507a083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Acne</topic><topic>Alopecia</topic><topic>Androgens</topic><topic>Antioxidants</topic><topic>Baldness</topic><topic>Birth control</topic><topic>Clinical trials</topic><topic>Drugs</topic><topic>Enzymes</topic><topic>Estrogens</topic><topic>Females</topic><topic>Hormones</topic><topic>In vivo methods and tests</topic><topic>Inflammation</topic><topic>Insulin resistance</topic><topic>Isoflavones</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Menstrual cycle</topic><topic>Menstruation</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Obesity</topic><topic>Ovaries</topic><topic>Oxidative stress</topic><topic>Phytoestrogens</topic><topic>Polycystic ovary syndrome</topic><topic>Review</topic><topic>Side effects</topic><topic>Stein-Leventhal syndrome</topic><topic>Testosterone</topic><topic>Weight control</topic><toplevel>online_resources</toplevel><creatorcontrib>Raihanah, Cut</creatorcontrib><creatorcontrib>Sukrasno, Sukrasno</creatorcontrib><creatorcontrib>Kurniati, Neng Fisheri</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biomedical reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raihanah, Cut</au><au>Sukrasno, Sukrasno</au><au>Kurniati, Neng Fisheri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)</atitle><jtitle>Biomedical reports</jtitle><addtitle>Biomed Rep</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>20</volume><issue>5</issue><spage>80</spage><epage>80</epage><pages>80-80</pages><artnum>80</artnum><issn>2049-9434</issn><eissn>2049-9442</eissn><abstract>Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on and clinical trial studies.</abstract><cop>England</cop><pub>Spandidos Publications</pub><pmid>38590945</pmid><doi>10.3892/br.2024.1768</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2049-9434
ispartof Biomedical reports, 2024-05, Vol.20 (5), p.80-80, Article 80
issn 2049-9434
2049-9442
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10999901
source PubMed Central
subjects Abdomen
Acne
Alopecia
Androgens
Antioxidants
Baldness
Birth control
Clinical trials
Drugs
Enzymes
Estrogens
Females
Hormones
In vivo methods and tests
Inflammation
Insulin resistance
Isoflavones
Medical research
Medicine, Experimental
Menstrual cycle
Menstruation
Metabolic disorders
Metabolism
Obesity
Ovaries
Oxidative stress
Phytoestrogens
Polycystic ovary syndrome
Review
Side effects
Stein-Leventhal syndrome
Testosterone
Weight control
title Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A47%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity%20of%20isoflavone%20in%20managing%20polycystic%20ovary%20syndrome%20symptoms%20(Review)&rft.jtitle=Biomedical%20reports&rft.au=Raihanah,%20Cut&rft.date=2024-05-01&rft.volume=20&rft.issue=5&rft.spage=80&rft.epage=80&rft.pages=80-80&rft.artnum=80&rft.issn=2049-9434&rft.eissn=2049-9442&rft_id=info:doi/10.3892/br.2024.1768&rft_dat=%3Cgale_pubme%3EA791885305%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c437t-59d09ba3f109280757974a754440469d824dfd7890c31ee082d9c01fe507a083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3039673838&rft_id=info:pmid/38590945&rft_galeid=A791885305&rfr_iscdi=true